Kellman Pharmaceutical Services (KPS) Selected as Functional Service Provider on GlobeImmune Clinical Trials

Share Article

KPS, an international full service CRO, is now working with GlobeImmune as a Functional Service Provider on clinical trials.

Kellman Pharmaceutical Services (KPS), an international full-service Contract Research Organization (CRO), is now working with GlobeImmune as a Functional Service Provider (FSP).

GlobeImmune Inc. is a private company developing therapeutic vaccines called Tarmogens for the treatment of cancer and infectious diseases.

As a FSP, KPS is providing more efficient data management and cost containment expertise through more efficient data monitoring and reporting.

“We were brought in to provide a more efficient monitoring alternative and are succeeding,” explains KPS President David Kelly. “We look forward to expanding our relationship and scope of services for the company in the future.”

About KPS
KPS is a global, innovative Contract Research Organization (CRO) providing services to pharmaceutical, biotechnology, medical device and related clinical trial industries. KPS offers a full range of services as a contract research organization and functional service provider including project and data management, quality assurance, monitoring visit reporting, safety quality assurance and regulatory affairs. For more information please visit http://www.kpslife.com or call 888-230-1577

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Andrew Lavin
Visit website